SEC 13F Intelligence

Founders Capital Management, LLC / REGN

Founders Capital Management, LLC’s Regeneron Pharmaceuticals Position

Does Founders Capital Management, LLC own Regeneron Pharmaceuticals (REGN)? Yes — 8.2K shares worth $6M (+1.04% of its 13F portfolio) as of Q1 2026.

Position Value
$6M
Q1 2026
Shares
8.2K
% of Portfolio
+1.04%
Quarters Held
30
currently held

Position History REGN

Reported value by quarter
Q4 ’18: $216,000Q4 ’18Q1 ’19: $237,000Q2 ’19: $181,000Q3 ’19: $163,000Q4 ’19: $217,000Q4 ’19Q1 ’20: $282,000Q2 ’20: $360,000Q3 ’20: $323,000Q4 ’20: $279,000Q4 ’20Q1 ’21: $2MQ2 ’21: $5MQ3 ’21: $5MQ4 ’21: $5MQ4 ’21Q1 ’22: $6MQ2 ’22: $5MQ3 ’22: $6MQ4 ’22: $6MQ4 ’22Q1 ’23: $7MQ2 ’23: $6MQ3 ’23: $7MQ4 ’23: $7MQ4 ’23Q1 ’24: $8MQ2 ’24: $8MQ3 ’24: $8MQ4 ’24: $6MQ4 ’24Q1 ’25: $5MQ2 ’25: $4MQ3 ’25: $5MQ4 ’25: $6MQ4 ’25Q1 ’26: $6Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20268.2K$6M+1.04%
Q4 20258.2K$6M+0.94%
Q3 20258.3K$5M+0.73%
Q2 20258.3K$4M+0.74%
Q1 20257.7K$5M+0.90%
Q4 20248.0K$6M+1.00%
Q3 20247.7K$8M+1.41%
Q2 20247.8K$8M+1.47%
Q1 20247.8K$8M+1.40%
Q4 20237.8K$7M+1.41%
Q3 20237.9K$7M+1.48%
Q2 20238.0K$6M+1.29%
Q1 20238.2K$7M+1.67%
Q4 20228.3K$6M+1.61%
Q3 20228.5K$6M+1.64%
Q2 20228.6K$5M+1.30%
Q1 20228.6K$6M+1.29%
Q4 20218.5K$5M+1.16%
Q3 20218.8K$5M+1.35%
Q2 20218.9K$5M+1.20%
Q1 20213.9K$2M+0.47%
Q4 2020577$279,000+0.08%
Q3 2020577$323,000+0.10%
Q2 2020577$360,000+0.12%
Q1 2020577$282,000+0.11%
Q4 2019577$217,000+0.07%
Q3 2019577$163,000+0.06%
Q2 2019577$181,000+0.06%
Q1 2019577$237,000+0.09%
Q4 2018577$216,000+0.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Founders Capital Management, LLC’s full portfolio or all institutional holders of REGN.